β-受体阻断剂在心血管疾病中的研究进展  

The application of β-blockers' progress

作　　者：薛李[1] 田宏[1] 王丽霞 XUE Li;TIAN Hong;WANG li-xia(Department of Pharmacy,the Third People's Hospital of Panzhihua,Panzhihua 617000,China)

机构地区：[1]攀枝花市第三人民医院药剂科,四川省攀枝花市617000

出　　处：《中国心血管病研究》2020年第3期282-284,共3页Chinese Journal of Cardiovascular Research

摘　　要：β-受体阻断剂作为经典的临床药物,广泛应用于各个领域.本文对近年来β-受体阻断剂在心血管疾病中的应用进行了详细的综述,并且对其临床应用要点进行了全面的梳理.p-blockers as a classic clinical drug,widely used in various fields.In this pape,a number of β-blockers in cardiovascular and non-cardiovascular's diseases were reviewed in detail in recent years and added the clinical application of the points,with a comprehensive combing.

关 键 词：Β-受体阻断药 心血管疾病 应用 

分 类 号：R54[医药卫生—心血管疾病]